TABLE 1.

Demographic and Clinical Characteristics of Study Patients

Variables	Patients (N = 8)
Age, y	62.0 (42.0–72.5)
BMI	24.0 (20.5–25.5)
Vaginal parity	2.0 (2.0–2.0)
POP-Q stage
Stage 2	6 (75%)
Stage 3	1 (12%)
Stage 4	1 (12%)
Vaginal estrogen use
No	3 (38%)
Yes	5 (62%)
Occult urinary incontinence from pessary use
No	5 (62%)
Yes	3 (38%)
POPDI-6	7.5 (4.5–8.5)
VAS	6.0 (5.0–8.5)

BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); POP-Q, Pelvic Organ Prolapse Quantification; POPDI-6, Pelvic Organ Prolapse Distress Inventory-6; VAS, visual analog scale.

Data are expressed as median with IQR or number of patients (% of total patients) unless otherwise specified.